Market revenue in 2022 | USD 1,102.9 million |
Market revenue in 2030 | USD 1,450.3 million |
Growth rate | 3.5% (CAGR from 2022 to 2030) |
Largest segment | Cdna synthesis & conversion |
Fastest growing segment | Data Analysis & Interpretation |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sample Collection, Purification, CDNA Synthesis & Conversion, PCR Analysis, Data Analysis & Interpretation |
Key market players worldwide | Catalent Inc, Qiagen NV, Quest Diagnostics Inc, Roche, Illumina Inc, PerkinElmer, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Agilent Technologies, GE HealthCare Technologies Inc Common Stock, Promega, Luminex, Takara Bio Inc, Danaher Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene expression market will help companies and investors design strategic landscapes.
Cdna synthesis & conversion was the largest segment with a revenue share of 27.26% in 2022. Horizon Databook has segmented the Canada gene expression market based on sample collection, purification, cdna synthesis & conversion, pcr analysis, data analysis & interpretation covering the revenue growth of each sub-segment from 2018 to 2030.
Canada is poised to witness lucrative growth in the market owing to advances in genomic & proteomic research in the country. Active presence of government as well as private organizations, which support developmental activities and spread awareness, is expected to influence growth.
The country is poised to exhibit significant growth due to increased investments in genomic & gene expression research. In November 2016, Canadian Journal of Microbiology published a review describing advancements in understanding the role of sigma factor in regulating bacterial gene expression.
In addition, in September 2016, BiogeniQ has announced to launch a personal pharmacogenetic test - ADHD Pharma Profile that evaluates eleven molecules and seven genes to determine drug responses of ADHD patients.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada gene expression market, including forecasts for subscribers. This country databook contains high-level insights into Canada gene expression market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account